To hear about similar clinical trials, please enter your email below

Trial Title: The Effectiveness and Safety of Ultrasound Elastography Guided Pleural Biopsy in the Differential Diagnosis of Benign and Malignant Pleural Effusion

NCT ID: NCT05781659

Condition: Pleural Effusion

Conditions: Official terms:
Pleural Effusion, Malignant
Pleural Effusion

Study type: Interventional

Study phase: N/A

Overall status: Recruiting

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Primary purpose: Diagnostic

Masking: None (Open Label)

Intervention:

Intervention type: Procedure
Intervention name: Ultrasound elastography guided pleural biopsy
Description: The patients will undergo ultrasound elastography (Aixplorer V, SuperSonic Imagine, FRA) guided pleural biopsy.
Arm group label: Ultrasound elastography guided pleural biopsy group

Intervention type: Procedure
Intervention name: Traditional ultrasound guided pleural biopsy
Description: The patients will undergo traditional ultrasound (Aixplorer V, SuperSonic Imagine, FRA) guided pleural biopsy.
Arm group label: Traditional ultrasound-guided pleural biopsy group

Summary: The goal of this clinical trial is to evaluate the diagnostic effcacy and safety of ultrasound elastography guided pleural biopsy in the differential diagnosis of benign and malignant pleural effusion. The main question it aims to answer are: the effectiveness and safety of ultrasound elastography guided pleural biopsy in the differential diagnosis of benign and malignant pleural effusion. Participants will undergo ultrasound elastography guided pleural biopsy or traditional ultrasound-guided pleural biopsy.

Criteria for eligibility:
Criteria:
Inclusion Criteria: 1. Patients with unexplained pleural effusion (patients with pleural effusion with negative aspiration) 2. Sign the informed consent form 3. The patient must have chest CT, biochemical examination of pleural fluid, cytological examination of pleural fluid and other data before operation Exclusion Criteria: 1. The cytological examination of pleural fluid indicates "highly suspicious" patients (unless the cytological examination results of patients are inconsistent with clinical manifestations and CT examination). The pleural fluid cytology proved to be malignant. Patients with severe pleural adhesion who cannot undergo medical thoracoscopic examination will not be randomly selected, and elastic ultrasound-guided biopsy can be performed after informed consent, as a subgroup of population analysis. Those who cannot tolerate closed pleural biopsy due to severe cardiopulmonary dysfunction and poor general condition Coagulation dysfunction. Leakage. The age is less than 18 years old. 2. The pleural fluid cytology proved to be malignant. 3. Patients with severe pleural adhesion who cannot undergo medical thoracoscopic examination will not be randomly selected, and elastic ultrasound-guided biopsy can be performed after informed consent, as a subgroup of population analysis. 4. Those who cannot tolerate closed pleural biopsy due to severe cardiopulmonary dysfunction and poor general condition 5. Coagulation dysfunction. 6. transudate 7. The age is less than 18 years old.

Gender: All

Minimum age: 18 Years

Maximum age: 90 Years

Healthy volunteers: No

Locations:

Facility:
Name: Anhui Chest Hospital

Address:
City: Hefei
Zip: 230000
Country: China

Status: Recruiting

Contact:
Last name: Tang Fei, MM

Facility:
Name: China-Japan Friendship Hospital

Address:
City: Beijing
Zip: 100000
Country: China

Status: Recruiting

Contact:
Last name: Tong Run, MD

Facility:
Name: Gui Zhou Provincial People's Hospital

Address:
City: Guiyang
Zip: 550000
Country: China

Status: Recruiting

Contact:
Last name: Ye Xianwei, MD

Facility:
Name: the Second Xiangya Hospital of Central South University

Address:
City: Changsha
Zip: 410000
Country: China

Status: Recruiting

Contact:
Last name: Chen Yan, MD

Facility:
Name: the First Affiliated Hospital of Nanchang University

Address:
City: Nanchang
Zip: 330000
Country: China

Status: Recruiting

Contact:
Last name: Xu Fei, MD

Facility:
Name: the First Hospital of China Medical University

Address:
City: Shenyang
Zip: 110000
Country: China

Status: Recruiting

Contact:
Last name: Ma Jiangwei, MD

Facility:
Name: The Tenth People's Hospital of Shenyang

Address:
City: Shenyang
Zip: 110000
Country: China

Status: Recruiting

Contact:
Last name: LI Chengjun, MM

Facility:
Name: the First People's Hospital of Yunnan Provience

Address:
City: Kunming
Zip: 650000
Country: China

Status: Recruiting

Contact:
Last name: Zhang Yunhui, MD

Facility:
Name: the Second Affiliated Hospital Zhejiang University School of Medicine

Address:
City: Hangzhou
Zip: 310000
Country: China

Status: Recruiting

Contact:
Last name: Xia Yang, MD

Start date: April 7, 2023

Completion date: December 31, 2024

Lead sponsor:
Agency: China-Japan Friendship Hospital
Agency class: Other

Source: China-Japan Friendship Hospital

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05781659

Login to your account

Did you forget your password?